We dont' have enough data on Sustained response vs relapse in those
coinfected pts receiving PEG + riba. if they behave like pts with HCV only,
then we would expect about 80% chance of keeping the response sustained. I
suspect the % will fall short of this in coinfection, but we await the
results of the ongoing trials to know exactly how much.